18 results
PRE 14A
TYRA
Tyra Biosciences Inc
5 Apr 24
Preliminary proxy
4:20pm
below are currently serving as our directors. Each of our directors brings to the Board significant leadership experience derived from … as a board member of another publicly-held company;
professional and academic experience relevant to our industry;
strong leadership skills;
diversity
8-K
EX-99.1
TYRA
Tyra Biosciences Inc
10 Aug 23
Tyra Biosciences Reports Second Quarter 2023 Financial Results and Highlights
4:21pm
(REarranged during Transfection kinase) driven cancers.
Corporate
Strengthened Leadership. TYRA made key senior appointments including Dr. Michael
8-K
EX-99.1
fzf6e3y
4 Aug 22
Tyra Biosciences Reports Second Quarter 2022 Financial Results and Highlights
4:23pm
DEF 14A
x592tqre
28 Apr 22
Definitive proxy
4:07pm
10-K
exw6m7sg1vo4ne7hlm
3 Mar 22
Annual report
4:31pm
10-Q
6kv oz62bag1eiis9pg
3 Nov 21
Quarterly report
4:31pm
8-K
EX-99.1
xqiu kno17z
3 Nov 21
Tyra Biosciences Reports Third Quarter 2021 Financial Results and Highlights
4:16pm
424B4
fzv e0i42wc7tac
15 Sep 21
Prospectus supplement with pricing info
4:10pm
S-1/A
qiq4iv 6n1td1jx17r
9 Sep 21
IPO registration (amended)
6:08am
S-1
20zc86605vx3bxir4gt
20 Aug 21
IPO registration
4:07pm
DRSLTR
njz rpmzl0
2 Jul 21
Correspondence regarding draft registration statement
12:00am
DRS/A
seyqvwe0prvacsrd
2 Jul 21
Draft registration statement (amended)
12:00am
UPLOAD
qk8nfwy06pacjcv3qk4
25 Jun 21
Letter from SEC
12:00am
DRS
4c7pv4kctwoz35n9l
28 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next